tiprankstipranks
Advertisement
Advertisement

OCS Stock Latest News

Three new option listings on March 17th
The FlyThree new option listings on March 17th
19d ago
OCS
GBFH
Oculis price target raised to $50 from $40 at Stifel
PremiumThe Fly
Oculis price target raised to $50 from $40 at Stifel
1M ago
OCS
Oculis Files 2025 Financials and Renews $100 Million ATM Program
PremiumCompany Announcements
Oculis Files 2025 Financials and Renews $100 Million ATM Program
1M ago
6K
OCS
Oculis files automatic mixed securities shelf
PremiumThe Fly
Oculis files automatic mixed securities shelf
1M ago
OCS
Oculis price target raised to $44 from $42 at H.C. Wainwright
PremiumThe Fly
Oculis price target raised to $44 from $42 at H.C. Wainwright
1M ago
OCS
Oculis: Advancing Late-Stage Ophthalmology Pipeline Drives Upside and Supports Buy Rating
PremiumRatingsOculis: Advancing Late-Stage Ophthalmology Pipeline Drives Upside and Supports Buy Rating
1M ago
OCS
Oculis: Strengthened Balance Sheet and Advancing Late-Stage Pipeline Support Buy Rating and Higher $40 Target Ahead of 2026 Pivotal Readouts
Premium
Ratings
Oculis: Strengthened Balance Sheet and Advancing Late-Stage Pipeline Support Buy Rating and Higher $40 Target Ahead of 2026 Pivotal Readouts
1M ago
OCS
Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline
Premium
Company Announcements
Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline
1M ago
6K
OCS
Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year
PremiumThe Fly
Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year
1M ago
OCS
Oculis Holding Ag (OCS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Oculis Holding Ag (OCS) Q4 Earnings Cheat Sheet
1M ago
OCS
J.P. Morgan Bangs the Drum on These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
J.P. Morgan Bangs the Drum on These 2 ‘Strong Buy’ Stocks
3M ago
GTX
OCS
Oculis (OCS): Privosergtor’s Breakthrough Profile in Optic Neuritis Supports First-in-Class Upside and Buy Rating
PremiumRatings
Oculis (OCS): Privosergtor’s Breakthrough Profile in Optic Neuritis Supports First-in-Class Upside and Buy Rating
3M ago
OCS
Oculis: Strengthening Clinical and Regulatory Momentum Supports Buy Rating and $42 Target
PremiumRatingsOculis: Strengthening Clinical and Regulatory Momentum Supports Buy Rating and $42 Target
3M ago
OCS
Morning Movers: OneStream surges following report of Hg takeover talks
Premium
The Fly
Morning Movers: OneStream surges following report of Hg takeover talks
3M ago
OS
DHI
Oculis up 9% after announcing breakthrough therapy designation for Privosegtor
Premium
The Fly
Oculis up 9% after announcing breakthrough therapy designation for Privosegtor
3M ago
OCS
Oculis price target raised to $40 from $35 at Stifel
PremiumThe Fly
Oculis price target raised to $40 from $35 at Stifel
4M ago
OCS
Oculis initiated with an Overweight at JPMorgan
PremiumThe Fly
Oculis initiated with an Overweight at JPMorgan
4M ago
OCS
Oculis initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Oculis initiated with an Outperform at LifeSci Capital
4M ago
OCS
Oculis price target lowered to $29 from $30 at BofA
PremiumThe Fly
Oculis price target lowered to $29 from $30 at BofA
5M ago
OCS
3 Best Stocks to Buy Now, 11/11/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 11/11/2025, According to Top Analysts
5M ago
OCS
ACHR
Oculis price target raised to $42 from $36 at H.C. Wainwright
Premium
The Fly
Oculis price target raised to $42 from $36 at H.C. Wainwright
5M ago
OCS
Oculis Holding: Promising Pipeline Developments and Strong Financial Position Support Buy Rating
Premium
Ratings
Oculis Holding: Promising Pipeline Developments and Strong Financial Position Support Buy Rating
5M ago
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >